Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q94491938)
Watch
English
Nitazoxanide/Azithromycin combination for COVID-19: A suggested new protocol for COVID-19 early management
scientific article published on 30 April 2020
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMCID
7192107
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32360581%20AND%20SRC:MED&resulttype=core&format=json
retrieved
15 May 2020
review article
1 reference
stated in
Europe PubMed Central
title
Nitazoxanide/Azithromycin combination for COVID-19: A suggested new protocol for COVID-19 early management
(English)
1 reference
stated in
Europe PubMed Central
PMCID
7192107
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32360581%20AND%20SRC:MED&resulttype=core&format=json
retrieved
15 May 2020
main subject
COVID-19
1 reference
based on heuristic
inferred from title
azithromycin
1 reference
based on heuristic
inferred from title
author
Mina Kelleni
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMCID
7192107
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32360581%20AND%20SRC:MED&resulttype=core&format=json
retrieved
15 May 2020
publication date
30 April 2020
1 reference
stated in
Europe PubMed Central
PMCID
7192107
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32360581%20AND%20SRC:MED&resulttype=core&format=json
retrieved
15 May 2020
published in
Pharmacological Research
1 reference
stated in
Europe PubMed Central
PMCID
7192107
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32360581%20AND%20SRC:MED&resulttype=core&format=json
retrieved
15 May 2020
page(s)
104874
1 reference
stated in
Europe PubMed Central
PMCID
7192107
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32360581%20AND%20SRC:MED&resulttype=core&format=json
retrieved
15 May 2020
cites work
Type 1 interferons as a potential treatment against COVID-19
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7192107
retrieved
11 February 2021
The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7192107
retrieved
11 February 2021
Hydroxychloroquine and azithromycin as a treatment of COVID‐19: results of an open‐label non‐randomized clinical trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7192107
retrieved
11 February 2021
Impact of ivermectin administered for scabies treatment on the prevalence of head lice in Atoifi, Solomon Islands
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7192107
retrieved
11 February 2021
Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double-blind, placebo-controlled trial.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7192107
retrieved
11 February 2021
Azithromycin induces anti-viral effects in cultured bronchial epithelial cells from COPD patients
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7192107
retrieved
11 February 2021
Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7192107
retrieved
11 February 2021
Coronaviruses - drug discovery and therapeutic options.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7192107
retrieved
11 February 2021
Nitazoxanide Use as Part of an Empiric Multi-Drug Regimen in Treating Children with Suspected Helicobacter pylori Infection
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7192107
retrieved
11 February 2021
Nitazoxanide: a first-in-class broad-spectrum antiviral agent
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7192107
retrieved
11 February 2021
Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7192107
retrieved
11 February 2021
The Binding Interactions of the Macrolide Endectocide Ivermectin with the Antibiotics Ampicillin, Chloramphenicol and Tetracycline HCL.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7192107
retrieved
11 February 2021
The efficacy of Bacillus Calmette-Guerin vaccinations for the prevention of acute upper respiratory tract infection in the elderly
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7192107
retrieved
11 February 2021
Azithromycin induces anti-viral responses in bronchial epithelial cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7192107
retrieved
11 February 2021
A Phase III Study of Recombinant Human Interferon Gamma to Prevent Opportunistic Infections in Advanced HIV Disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7192107
retrieved
11 February 2021
Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7192107
retrieved
11 February 2021
Identifiers
DOI
10.1016/J.PHRS.2020.104874
1 reference
stated in
Europe PubMed Central
PMCID
7192107
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32360581%20AND%20SRC:MED&resulttype=core&format=json
retrieved
15 May 2020
COVIDWHO ID
covidwho-155135
0 references
Dimensions Publication ID
1127245901
1 reference
stated in
Dimensions COVID-19 publications, datasets and clinical trials
DOI
10.6084/M9.FIGSHARE.11961063
retrieved
28 May 2020
PMCID
7192107
1 reference
stated in
Europe PubMed Central
PMCID
7192107
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32360581%20AND%20SRC:MED&resulttype=core&format=json
retrieved
15 May 2020
PubMed ID
32360581
1 reference
stated in
Europe PubMed Central
PMCID
7192107
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32360581%20AND%20SRC:MED&resulttype=core&format=json
retrieved
15 May 2020
Semantic Scholar corpus ID
216881297
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
